Oakley GP Jr, Adams MJ, Dickinson CM. More folic acid for everyone, now.
J Nutr. 1996;126:751S-755S.
Wald NJ, et al. Quantifying the effect of folic acid.
Lancet. 2001;15;358:2069-2073.
Senti FR, Pilch SM. Analysis of folate data from the second National Health and Nutrition Examination Survey (NHANES II).
J Nutr.
1985;115:1398-1402.
Hoppner K, Lampi B. Bioavailability of folate following ingestion of cholestyramine in the rat.
Int J Vitam Nutr Res.
1991;61:130-134.
West RJ, Lloyd JK. The effect of cholestyramine on intestinal absorption.
Gut.
1975;16:93-98.
Hendel J, Dam M, Gram L, et al. The effects of carbamazepine and valproate on folate metabolism in man.
Acta Neurol Scand.
1984;69:226-231.
Reynolds EH, Milner G, Matthews DM, et al. Anticonvulsant therapy, megaloblastic haemopoiesis and folic acid metabolism.
QJM.
1966;35:521-537.
Lewis DP, Van Dyke DC, Stumbo PJ, et al. Drug and environmental factors associated with adverse pregnancy outcomes. Part I: Antiepileptic drugs, contraceptives, smoking, and folate.
Ann Pharmacother.
1998;32:802-817.
Lewis DP, Van Dyke DC, Willhite LA, et al. Phenytoin-folic acid interaction.
Ann Pharmacother.
1995;29:726-735.
Berg MJ, Stumbo PJ, Chenard CA, et al. Folic acid improves phenytoin pharmacokinetics.
J Am Diet Assoc.
1995;95:352-356.
Ono H, Sakamoto A, Eguchi T, et al. Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants.
Metabolism.
1997;46:959-962.
Kishi T, Fujita N, Eguchi T, et al. Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy.
J Neurol Sci.
1997;145:109-112.
Biale Y, Lewenthal H. Effect of folic acid supplementation on congenital malformations due to anticonvulsive drugs.
Eur J Obstet Gynecol Reprod Biol.
1984;18:211-216.
Baum CL, Selhub J, Rosenberg IH. Antifolate actions of sulfasalazine on intact lymphocytes.
J Lab Clin Med.
1981;97:779-784.
Selhub J, Dhar GJ, Rosenberg IH. Inhibition of folate enzymes by sulfasalazine.
J Clin Invest.
1978;61:221-224.
Krogh Jensen M, Ekelund S, Svendsen L. Folate and homocysteine status and haemolysis in patients treated with sulphasalazine for arthritis.
Scand J Clin Lab Invest.
1996;56:421-429.
Baggott JE, Morgan SL, Ha T, et al. Inhibition of folate-dependent enzymes by non-steroidal anti-inflammatory drugs.
Biochem J.
1992;282(Pt 1):197-202.
Lawrence VA, Loewenstein JE, Eichner ER. Aspirin and folate binding: in vivo and in vitro studies of serum binding and urinary excretion of endogenous folate.
J Lab Clin Med.
1984;103:944-948.
Lieberman FL, Bateman JR. Megaloblastic anemia possibly induced by triamterene in patients with alcoholic cirrhosis.
Ann Intern Med.
1968;68:168-173.
Mason JB, Zimmerman J, Otradovec CL, et al. Chronic diuretic therapy with moderate doses of triamterene is not associated with folate deficiency.
J Lab Clin Med.
1991;117:365-369.
Amos RJ, Amess JA, Hinds CJ, et al. Investigations into the effect of nitrous oxide anaesthesia on folate metabolism in patients receiving intensive care.
Chemioterapia.
1985;4:393-399.
Ermens AA, Refsum H, Rupreht J, et al. Monitoring cobalamin inactivation during nitrous oxide anesthesia by determination of homocysteine and folate in plasma and urine.
Clin Pharmacol Ther.
1991;49:385-393.
Amos RJ, Amess JA, Hinds CJ, et al. Incidence and pathogenesis of acute megaloblastic bone-marrow change in patients receiving intensive care.
Lancet.
1982;2:835-838.
Koblin DD, Tomerson BW, Waldman FM, et al. Effect of nitrous oxide on folate and vitamin B
12
metabolism in patients.
Anesth Analg.
1990;71:610-617.
Nunn JF, Chanarin I, Tanner AG, et al. Megaloblastic bone marrow changes after repeated nitrous oxide anaesthesia. Reversal with folinic acid.
Br J Anaesth.
1986;58:1469-1470.
Kahn SB, Fein SA, Brodsky I. Effects of trimethoprim on folate metabolism in man.
Clin Pharmacol Ther.
1968;9:550-560.
Vinnicombe HG, Derrick JP. Dihydropteroate synthase from
Streptococcus pneumoniae: characterization of substrate binding order and sulfonamide inhibition.Biochem Biophys Res Commun.
1999;258:752-757.
Russell RM, Golner BB, Krasinski SD, et al. Effect of antacid and H
2
receptor antagonists on the intestinal absorption of folic acid.
J Lab Clin Med.
1988;112:458-463.
Stumm W, Morgan JJ.
Aquatic Chemistry: An Introduction Emphasizing Chemical Equilibria in Natural Waters.
2nd ed. New York, NY: Wiley; 1981:240.
Deleu D, Louon A, Sivagnanam S, et al. Long-term effects of nitrous oxide anaesthesia on laboratory and clinical parameters in elderly Omani patients: a randomized double-blind study.
J Clin Pharm Ther.
2000;25:271-277.
Hernandez-Diaz S, Werler MM, Walker AM, et al. Folic acid antagonists during pregnancy and the risk of birth defects.
N Engl J Med. 2000;343:1608-1614.
Steegers-Theunissen RPM, Van Rossum JM, Steegers EAP, et al. Sub-50 oral contraceptives affect folate kinetics.
Gynecol Obstet Invest.
1993;36:230-233.
Mooij PNM, Thomas CMG, Doesburg WH, et al. Multivitamin supplementation in oral contraceptive users.
Contraception.
1991;44:277-288.
Green TJ, Houghton LA, Donovan U, et al. Oral contraceptives did not affect biochemical folate indexes and homocysteine concentrations in adolescent females.
J Am Diet Assoc.
1998;98:49-55.
Russell RM, Dutta SK, Oaks EV, et al. Impairment of folic acid absorption by oral pancreatic extracts.
Dig Dis Sci. 1980;25:369-373.
Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects.
JAMA. 1993;269:1257-1261.
Milunsky A, Jick H, Jick SS, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects.
JAMA.
1989;262:2847-2852.
Hernandez-Diaz S, Werler MM, Walker AM, et al. Folic acid antagonists during pregnancy and the risk of birth defects.
N Engl J Med. 2000;343:1608-1614.
Rimm EB, Willett WC, Hu FB, et al. Folate and vitamin B
6
from diet and supplements in relation to risk of coronary heart disease among women.
JAMA. 1998;279:359-364.
Moghadasian MH, McManus BM, Frolich JJ. Homocyst(e)ine and coronary artery disease.
Arch Intern Med. 1997;157:2299-2308.
Ubbink JB, van der Merwe A, Vermaak WJH, et al. Hyperhomocysteinemia and the response to vitamin supplementation.
Clin Investig. 1993;71:993-998.
den Heijer M, Brouwer IA, Bos GMJ, et al. Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers.
Arterioscler Thromb Vasc Biol. 1998;18:356-361.
Ward M, McNulty H, McPartlin J, et al. Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid.
QJM. 1997;90:519-524.
Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.
JAMA. 1997;277:1775-1781.
Wald NJ, Watt HC, Law MR, et al. Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention.
Arch Intern Med.
1998;158:862-867.
Wald DS, Bishop L, Wald NJ, et al. Randomized trial of folic acid supplementation and serum homocysteine levels.
Arch Intern Med.
2001;161:695-700.
Oakley GP Jr, Adams MJ, Dickinson CM. More folic acid for everyone, now.
J Nutr. 1996;126:751S-755S.
Godfrey PSA, Toone BK, Carney MWP, et al. Enhancement of recovery from psychiatric illness by methylfolate.
Lancet. 1990;336:392-395.
Botez MI. Folate deficiency and neurological disorders in adults.
Med Hypotheses. 1976;2:135-140.
Alpert JE, Fava M. Nutrition and depression: the role of folate.
Nutr Rev. 1997;55:145-149.
Passeri M, Cucinotta D, Abate G, et al. Oral 5'-methyltetrahydrofolic acid in senile organic mental disorders with depression: Results of a double-blind multicenter study.
Aging (Milano). 1993;5:63-71.
Coppen A, Swade C, Jones SA, et al. Depression and tetrahydrobiopterin: the folate connection.
J Affect Disord. 1989;16:103-107.
Heseker H, Kbler W, Pudel V, et al. Psychological disorders as early symptoms of a mild-to-moderate vitamin deficiency.
Ann N Y Acad Sci. 1992;669:352-357.
Crellin R, Bottiglieri T, Reynolds EH. Folates and psychiatric disorders. Clinical potential.
Drugs. 1993;45:623-636.
Coppen A, Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial.
J Affect Disord. 2000;60:121-130.
Butterworth CE Jr. Effect of folate on cervical cancer. Synergism among risk factors.
Ann N Y Acad Sci. 1992;669:293-299.
Kim Y-I, Mason JB. Folate, epithelial dysplasia and colon cancer.
Proc Assoc Am Physicians. 1995;107:218-227.
Heimburger DC. Localized deficiencies of folic acid in aerodigestive tissues.
Ann N Y Acad Sci. 1992;669:87-96.
Zhang S, Hunter DJ, Hankinson SE, et al. A prospective study of folate intake and the risk of breast cancer.
JAMA.
1999;281:1632-1637.
Stolzenberg-Solomon RZ, Pietinen P, Barrett MJ, et al. Dietary and other methyl-group availability factors and pancreatic cancer risk in a cohort of male smokers.
Am J Epidemiol.
2001;153:680-687.
Heimburger DC. Localized deficiencies of folic acid in aerodigestive tissues.
Ann N Y Acad Sci. 1992;669:87-96.
Giovannucci E, Stampfer MJ, Colditz GA, et al. Folate, methionine, and alcohol intake and risk of colorectal adenoma.
J Natl Cancer Inst;
1993;85:875-884.
Giovannucci E, Stampfer MJ, Colditz GA, et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study.
Ann Intern Med.
1998;129:517-524.
Baron JA, Sandler RS, Haile RW, et al. Folate intake, alcohol consumption, cigarette smoking, and risk of colorectal adenomas.
J Natl Cancer Inst.
1998;90:57-62.
Butterworth CE Jr, Hatch KD, Gore H, et al. Improvement in cervical dysplasia associated with folic acid therapy in users of oral contraceptives.
Am J Clin Nutr.
1982;35:73-82.
Butterworth CE Jr, Hatch KD, Soong SJ, et al. Oral folic acid supplementation for cervical dysplasia: A clinical intervention trial.
Am J Obstet Gynecol.
1992;166:803-809.
Snowdon DA, Tully CL, Smith CD, et al. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun Study.
Am J Clin Nutr.
2000;71:993-998.
van Ede AE, Laan RF, Rood MJ, et al. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study.
Arthritis Rheum.
2001;44:1515-1524.
Morgan SL, Baggott JE, Vaughn WH, et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial.
Ann Intern Med.
1994;121:833-841.
Griffith SM, Fisher J, Clarke S, et al. Do patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term?
Rheumatology (Oxford).
2000;39:1102-1109.
Hunt PG, Rose CD, McIlvain-Simpson G, et al. The effects of daily intake of folic acid on the efficacy of methotrexate therapy in children with juvenile rheumatoid arthritis. A controlled study.
J Rheumatol.
1997;24:2230-2232.
Duhra P. Treatment of gastrointestinal symptoms associated with methotrexate therapy for psoriasis.
J Am Acad Dermatol.
1993;28:466-469.
Gori T, Burstein JM, Ahmed S, et al. Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study.
Circulation.
2001;104:1119-1123.
Oster KA. Evaluation of serum cholesterol reduction and xanthine oxidase inhibition in the treatment of atherosclerosis.
Recent Adv Stud Cardiac Struct Metab. 1973;3:73-80.
Boss GR, Ragsdale RA, Zettner A, et al. Failure of folic acid (pteroylglutamic acid) to affect hyperuricemia
. J Lab Clin Med. 1980;96:783-789.
Flouvier B, Devulder B. Folic acid, xanthine oxidase, and uric acid [letter].
Ann Intern Med.
1978;88:269.
Boss GR, Ragsdale RA, Zettner A, et al. Failure of folic acid (pteroylglutamic acid) to affect hyperuricemia
. J Lab Clin Med. 1980;96:783-789.
O'Keeffe ST. Restless legs syndrome. A review.
Arch Intern Med.
1996;156:243-248.
Brattstrom LE, Hultberg BL, Hardebo JE. Folic acid responsive postmenopausal homocysteinemia.
Metabolism.
1985;34:1073-1077.
Flynn MA, Irvin W, Krause G. The effect of folate and cobalamin on osteoarthritic hands.
J Am Coll Nutr. 1994;13:351-356.
Kremer JM, Bigaouette J. Nutrient intake of patients with rheumatoid arthritis is deficient in pyridoxine, zinc, copper, and magnesium.
J Rheumatol. 1996;23:990-994.
Montes LF, Diaz ML, Lajous J, et al. Folic acid and vitamin B
12
in vitiligo: a nutritional approach.
Cutis. 1992;50:39-42.
Coppen A, Abou-Saleh MT. Plasma folate and affective morbidity during long-term lithium therapy.
Br J Psychiatry.
1982;141:87-89.
Coppen A, Chaudhry S, Swade C. Folic acid enhances lithium prophylaxis.
JAffect Disord.
1986;10:9-13.
Callaghan TJ. The effect of folic acid on seborrheic dermatitis.
Cutis.
1967;3:583-588.
Juhlin L, Olsson MJ. Improvement of vitiligo after oral treatment with vitamin B12 and folic acid and the importance of sun exposure.
Acta Derm Venereol (Stockh). 1997;77:460-462.
Kim SM, Kim YK, Hann S-K. Serum levels of folic acid and vitamin B12 in Korean patients with vitiligo.
Yonsei Med J. 1999;40:195-198.
Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects.
JAMA. 1993;269:1257-1261.
Milunsky A, Jick H, Jick SS, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects.
JAMA. 1989;262:2847-2852.
Hernandez-Diaz S, Werler MM, Walker AM, et al. Folic acid antagonists during pregnancy and the risk of birth defects.
N Engl J Med. 2000;343:1608-1614.
Rimm EB, Willett WC, Hu FB, et al. Folate and vitamin B
6
from diet and supplements in relation to risk of coronary heart disease among women.
JAMA. 1998;279:359-364.
Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project
. JAMA.
1997;277:1775-1781.
Wald NJ, Watt HC, Law MR, et al. Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention.
Arch Intern Med.
1998;158:862-867.
Moghadasian MH, McManus BM, Frohlich JJ. Homocysteine and coronary artery disease.
Arch Intern Med. 1997;157:2299-2308.
Ubbink JB, van der Merwe A, Vermaak WJH, et al. Hyperhomocysteinemia and the response to vitamin supplementation.
Clin Investig. 1993;71:993-998.
den Heijer M, Brouwer IA, Bos GMJ, et al. Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers.
Arterioscler Thromb Vasc Biol. 1998;18:356-361.
Ward M, McNulty H, McPartlin J, et al. Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid.
QJM. 1997;90:519-524.
Wald NJ, Watt HC, Law MR, et al. Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention.
Arch Intern Med.
1998;158:862-867.
Wald DS, Bishop L, Wald NJ, et al. Randomized trial of folic acid supplementation and serum homocysteine levels.
Arch Intern Med.
2001;161:695-700.
Coppen A, Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial.
J Affect Disord. 2000;60:121-130.
van Ede AE, Laan RF, Rood MJ, et al. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study.
Arthritis Rheum.
2001;44:1515-1524.
Morgan SL, Baggott JE, Vaughn WH, et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial.
Ann Intern Med.
1994;121:833-841.
Griffith SM, Fisher J, Clarke S, et al. Do patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term?
Rheumatology (Oxford).
2000;39:1102-1109.
Hunt PG, Rose CD, McIlvain-Simpson G, et al. The effects of daily intake of folic acid on the efficacy of methotrexate therapy in children with juvenile rheumatoid arthritis. A controlled study.
J Rheumatol.
1997;24:2230-2232.
Duhra P. Treatment of gastrointestinal symptoms associated with methotrexate therapy for psoriasis.
J Am Acad Dermatol.
1993;28:466-469.
Butterworth CE Jr, Tamura T. Folic acid safety and toxicity: a brief review.
Am J Clin Nutr. 1989;50:353-358.
Lewis DP, Van Dyke DC, Willhite LA, et al. Phenytoin-folic acid interaction.
Ann Pharmacother.
1995;29:726-735.
Berg MJ, Stumbo PJ, Chenard CA, et al. Folic acid improves phenytoin pharmacokinetics.
J Am Diet Assoc.
1995;95:352-356.
Ono H, Sakamoto A, Eguchi T, et al. Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants.
Metabolism.
1997;46:959-962.
Kishi T, Fujita N, Eguchi T, et al. Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy.
J Neurol Sci.
1997;145:109-112.
Lewis DP, Van Dyke DC, Stumbo PJ, et al. Drug and environmental factors associated with adverse pregnancy outcomes. Part I: Antiepileptic drugs, contraceptives, smoking, and folate.
Ann Pharmacother.
1998;32:802-817.
Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B
6, folate, vitamin B
12, pantothenic acid, biotin, and choline. Available at:
http://www.nap.edu. Accessed October 4, 2001.
Cembrowski GS, Zhang MM, Prosser CI, Higgins T. Folate is not what it is cracked up to be.
Arch Intern Med.
1999;159:2747-2748.
Venn BJ, Mann JI, Williams SM, et al. Assessment of three levels of folic acid on serum folate and plasma homocysteine: a randomised placebo-controlled double-blind dietary intervention trial.
Eur J Clin Nutr.
2002;56:748-754.
Ortiz Z, Shea B, Suarez-Almazor ME, et al. The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A meta-analysis of randomized controlled trials.
J Rheumatol.
1998;25:36-43.
Van Ede AE, Laan RF, Blom HJ, et al. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.
Rheumatology (Oxford). 2002;41:658-665.
Morgan SL, Baggott JE, Lee JY, Alarcon GS. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention.
J Rheumatol.
1998;25:441-446.
Mangoni AA, Sherwood RA, Swift CG, et al. Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial.
J Intern Med. 2002;252:497-503.
Wulffele MG, Kooy A, Lehert P, et al. Effect of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomised, placebo-controlled trial [abstract]. American Diabetes Association 63rd Annual Scientific Sessions; New Orleans, Louisiana; June 13-17, 2003: 732-P.
Van Oort FV, Melse-Boonstra A, Brouwer IA, et al. Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study.
Am J Clin Nutr. 2003;77:1318-1323.
Wrone EM, Hornberger JM, Zehnder JL, et al. Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease.
J Am Soc Nephrol. 2004;15:420-426.
Lange H, Suryapranata H, De Luca G, et al. Folate therapy and in-stent restenosis after coronary stenting.
N Engl J Med. 2004;350:2673-2681.
Papakostas GI, Petersen T, Mischoulon D, et al. Serum folate, vitamin B(12), and homocysteine in major depressive disorder, part 1: predictors of clinical response in fluoxetine-resistant depression.
J Clin Psychiatry. 2004;65:1090-1095.
Diculescu M, Ciocirlan M, Ciocirlan M, et al. Folic acid and sulfasalazine for colorectal carcinoma chemoprevention in patients with ulcerative colitis: the old and new evidence.
Rom J Gastroenterol. 2004;12:283-286.
Hoekstra M, Van Ede AE, Haagsma CJ, et al. Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis.
Ann Rheum Dis. 2003;62:423-426.
Papakostas GI, Petersen T, Mischoulon D, et al. Serum folate, vitamin B(12), and homocysteine in major depressive disorder, part 1: predictors of clinical response in fluoxetine-resistant depression.
J Clin Psychiatry. 2004;65:1090-1095.
Charles D, Andy R Ness AR , Campbell D, et al. Taking folate in pregnancy and risk of maternal breast cancer
BMJ. 2004;329:1375-1376.
Lawrence JM, Watkins ML, Chiu V, et al. Do racial and ethnic differences in serum folate values exist after food fortification with folic acid?
Am J Obstet Gynecol.
2006;194:520-526.
Asadi-Pooya AA, Ghetmiri E. Folic acid supplementation reduces the development abnormalities in children receiving carbamazepine.
Epilepsy Behav.
2005 Dec 24. [Epub ahead of print].
[no authors listed] Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials.
Am J Clin Nutr.
2005;82:806-812.
Asadi-Pooya AA, Ghetmiri E. Folic acid supplementation reduces the development abnormalities in children receiving carbamazepine.
Epilepsy Behav.
2005 Dec 24. [Epub ahead of print].
Pathansali R, Mangoni AA, Creagh-Brown B, et al. Effects of folic acid supplementation on psychomotor performance and hemorheology in healthy elderly subjects.
Arch Gerontol Geriatr. 2005 Dec 13. [Epub ahead of print].
Lawrence JM, Watkins ML, Chiu V, et al. Do racial and ethnic differences in serum folate values exist after food fortification with folic acid?
Am J Obstet Gynecol.
2006;194:520-526.
Lin PT, Lee BJ, Chang HH, et al. Low-dose folic acid supplementation reduces homocysteine concentration in hyperhomocysteinemic coronary artery disease patients.
Nutr Res. 2006;26:460-466.
Bazzano LA, Reynolds K, Holder KN, et al. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials.
JAMA. 2006;296:2720-2426.
Durga J, Verhoef P, Anteunis LJ, et al. Effects of folic acid supplementation on hearing in older adults: a randomized, controlled trial.
Ann Intern Med. 2007;146:1-9.
Durga J, van Boxtel MP, Schouten EG, et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial.
Lancet. 2007;369:208-216.
Wang X, Qin X, Demirtas H, et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis.
Lancet.
2007;369:1876-1882.
Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.
JAMA.
2007;297:2351-2359.
Gilbody S, Lightfoot T, Sheldon T. Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity.
J Epidemiol Community Health.
2007;61:631-637.
Gamble MV, Liu X, Slavkovich V, et al. Folic acid supplementation lowers blood arsenic.
Am J Clin Nutr.
2007;86:1202-1209.
Alemdaroglu NC, Dietz U, Wolffram S, et al. Influence of green and black tea on folic acid pharmacokinetics in healthy volunteers: potential risk of diminished folic acid bioavailability.
Biopharm Drug Dispos.
2008 Jun 12.
Jaszewski R, Misra S, Tobi M, et al. Folic acid supplementation inhibits recurrence of colorectal adenomas: A randomized chemoprevention trial.
World J Gastroenterol.
2008;14:4492-4498.
Ebbing M, Bleie O, Ueland PM, et al. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial.
JAMA.
2008;300:795-804.
Walker JG, Mackinnon AJ, Batterham P, et al. Mental health literacy, folic acid and vitamin B12, and physical activity for the prevention of depression in older adults: randomised controlled trial.
Br J Psychiatry.
2010;197(1):45-54.
De-Regil L, Fernandez-Gaxiola A, Dowswell T, Pena-Rosas J. Effects and safety of periconceptional folate supplementation for preventing birth defects.
Cochrane Database Syst Rev.
2010;(10):CD007950.
Roth C, Magnus P, Schjølberg S, et al. Folic acid supplements in pregnancy and severe language delay in children.
JAMA.
2011;306(14):1566-1573.
Dietary supplement fact sheet: folate. Office of Dietary Supplements website. Available at: http://ods.od.nih.gov/factsheets/Folate-HealthProfessional/. Accessed September 7, 2012.
Dietary supplement fact sheet: folate. Office of Dietary Supplements website. Available at: http://ods.od.nih.gov/factsheets/Folate-HealthProfessional/. Accessed May 28, 2013.
MTR. Genetics Home Reference website. Available at: http://ghr.nlm.nih.gov/gene/MTR. Accessed May 28, 2013.
Obeid R, Holzgreve W, Pietrzik K. Is 5-methyltetrahydrofolate an alternative to folic acid for the prevention of neural tube defects?
J Perinat Med. 2013; Epub ahead of print.
Pietrzik K, Bailey L, Shane B.
Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics.
Clin Pharmacokinet. 2010;49(8):535-548.